Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Tagraxofusp in Combination with Azacitidine and Venetoclax in Newly Diagnosed CD123+ Acute Myeloid Leukemia, Expansion Cohort of a Phase 1b Multicenter Trial

Blood (2023) 142 (Supplement 1): 4277.

https://doi.org/10.1182/blood-2023-180010

Published: 2023

Journal Articles

Daratumumab for Refractory Autoimmune Leukopenia: A Case Report

Xiaoyang Wang, Michael Guo, Karen Seiter, Amir Steinberg, Fauzia Paracha, Christopher R. Reilly, Fouzia Alam Shakil, Delong Liu

Blood (2023) 142 (Supplement 1): 5388.

https://doi.org/10.1182/blood-2023-181141

Published: 2023

Journal Articles

DDX41 : here, there…and everywhere

Christopher R. Reilly, Andrew A. Lane

Blood (2023) 142 (14): 1177–1178.

https://doi.org/10.1182/blood.2023021850

Published: 2023

Journal Articles

Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances

Christopher R. Reilly, Akiko Shimamura

Blood (2023) 141 (13): 1513–1523.

https://doi.org/10.1182/blood.2022017739

Published: 2023

Journal Articles

Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel

Blood (2022) 140 (Supplement 1): 646–647.

https://doi.org/10.1182/blood-2022-166322

Published: 2022

Journal Articles

Outcomes of Hematologic Complications in Shwachman Diamond Syndrome: High Risk Features and Implications for Surveillance

Ashley Galvin, Chris R. Reilly, Maggie Malsch, Sara Loveless, Joseph H. Antin, Stella M Davies, Courtney D. DiNardo, Adam Lane, Coleman Lindsley, Taizo A. Nakano, Richard Cooper, Katherine Coyne, Claire Dusa, Margret Joos, Mark D. Fleming, Kasiani C. Myers, Akiko Shimamura

Blood (2022) 140 (Supplement 1): 2949–2950.

https://doi.org/10.1182/blood-2022-164969

Published: 2022

Journal Articles

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Blood (2021) 138 (10): 898–911.

https://doi.org/10.1182/blood.2021011075

Published: 2021

Includes: Supplemental data

Journal Articles

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Mikko Myllymäki, Robert Redd, Christopher R. Reilly, Wael Saber, Stephen R. Spellman, Christopher J. Gibson, Zhen-Huan Hu, Tao Wang, Esther H. Orr, Jaclyn G. Grenier, Maxine M. Chen, David P. Steensma, Corey Cutler, Immaculata De Vivo, Joseph H. Antin, Donna Neuberg, Suneet Agarwal, R. Coleman Lindsley

Blood (2020) 136 (26): 3070–3081.

https://doi.org/10.1182/blood.2020005397

Published: 2020

Includes: Supplemental data

Journal Articles

Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Hematopoietic Stem Cells in JAK2 -Mutant Myeloproliferative Neoplasms

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141643

Published: 2020

Journal Articles

Multicenter Analysis of Clinical Characteristics and Long-Term Outcomes of Transjugular Intrahepatic Portosystemic Shunt Procedure for MPN-Associated Portal Hypertension

Christopher R Reilly, MD, Daria V. Babushok, MD PhD, Karlyn Martin, MD, Jerry L. Spivak, MD, Michael Streiff, MD, Brady Stein, MD, Alison R Moliterno, MD, Elizabeth O. Hexner, MD

Blood (2016) 128 (22): 1943.

https://doi.org/10.1182/blood.V128.22.1943.1943

Published: 2016

Journal Articles

Clinical Characteristics and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Procedure for Portal Hypertension Secondary to Myeloproliferative Neoplasms

Christopher R Reilly, MD, Daria V. Babushok, MD PhD, Ranjeeta Bahirwani, MD, Jeffery Mondschein, MD, Elizabeth O. Hexner, MD

Blood (2015) 126 (23): 1612.

https://doi.org/10.1182/blood.V126.23.1612.1612

Published: 2015

Journal Articles

Impaired Ability of Bone Marrow Stromal Cells to Support B-Lymphopoiesis With Age

Robert P. Stephan, Colette R. Reilly, Pamela L. Witte

Blood (1998) 91 (1): 75–88.

https://doi.org/10.1182/blood.V91.1.75

Published: 1998

Journal Articles

Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1

AA Higazi, A Mazar, J Wang, R Reilly, J Henkin, D Kniss, D Cines

Blood (1996) 87 (9): 3545–3549.

https://doi.org/10.1182/blood.V87.9.3545.bloodjournal8793545

Published: 1996

NARROW

Tagraxofusp in Combination with Azacitidine and Venetoclax in Newly Diagnosed CD123+ Acute Myeloid Leukemia, Expansion Cohort of a Phase 1b Multicenter Trial

Daratumumab for Refractory Autoimmune Leukopenia: A Case Report

DDX41 : here, there…and everywhere

Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances

Patients with Deleterious Germline Variants in STXBP2 Develop Toxicity after CAR-T Cell Therapy with Axicabtagene Ciloleucel

Outcomes of Hematologic Complications in Shwachman Diamond Syndrome: High Risk Features and Implications for Surveillance

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome

Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Hematopoietic Stem Cells in JAK2 -Mutant Myeloproliferative Neoplasms

Multicenter Analysis of Clinical Characteristics and Long-Term Outcomes of Transjugular Intrahepatic Portosystemic Shunt Procedure for MPN-Associated Portal Hypertension

Clinical Characteristics and Outcomes of Transjugular Intrahepatic Portosystemic Shunt Procedure for Portal Hypertension Secondary to Myeloproliferative Neoplasms

Impaired Ability of Bone Marrow Stromal Cells to Support B-Lymphopoiesis With Age

Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only